Cetirizine + Paracetamol + Phenylephrine Syrup

This syrup belongs to the Syrups category within the Cough & Cold, Anti-Histamines, and Analgesics & Pain Relief therapeutic segments.

Saar Biotech manufactures this syrup from our manufacturing facility in Baddi.

At Saar Biotech, we manufacture this syrup using a controlled oral syrup manufacturing process that ensures dose uniformity and palatability.

• Three-API Uniformity: All actives are uniformly distributed for consistent dosing.
• Taste Masking: Mixed fruit and orange flavours ensure patient acceptance.
• pH and Stability Management: All actives remain chemically stable for 24 months.
• 60ml and 100ml Pack Coverage: Suitable for acute cold treatment courses.

This syrup is manufactured and supplied by Saar Biotech for the following established clinical indications:

• Common Cold: Symptomatic relief of cold symptoms
• Fever: Antipyretic action for fever relief
• Nasal Congestion: Decongestant action for blocked nose
• Allergic Rhinitis: Relief from sneezing and runny nose

Schedule H — Requires valid medical prescription.

Cetirizine blocks H1 histamine receptors. Paracetamol inhibits prostaglandin synthesis. Phenylephrine causes nasal vasoconstriction.

Manufacturing Integrity

• Three-API Compatibility: All actives remain stable in the syrup vehicle.
• pH Stability: The syrup base is pH-buffered to maintain active stability.

Saar Biotech provides Third-Party Manufacturing for this syrup from our oral liquid manufacturing facility in Baddi, Himachal Pradesh.

• Facility: Oral liquid manufacturing area with controlled processing, automated bottle filling, capping, labelling, and carton packing lines.
• Capacity: Scalable from brand-entry launches to large commercial batches.
• Quality Lab: In-house GLP-certified lab with HPLC assay, pH, viscosity, MLT, and fill volume checks.
• Turnaround: New orders — 30 to 45 working days. Repeat orders — 20 to 25 working days.
• Packaging: 60ml and 100ml PET or dark amber bottles; sticker label, metallic label, measuring cup, printed cap.
• MOQ: Starting at 5,000–10,000 units per SKU.

1. Warehouse Conditions: Store below 30°C in a cool, dry environment. Protect from direct sunlight.
2. Light Protection: Amber bottles and outer cartons protect from photo-degradation.
3. Measuring Cup Use: A calibrated measuring cap ensures accurate dosing.

Every commercial batch is quarantined until it passes a comprehensive analytical release protocol:

• Three-API HPLC Assay: Simultaneous quantification of all actives.
• pH Testing: Verification of pH within stability-appropriate specification range.
• Microbial Limit Testing (MLT): IP-compliant microbiological testing.
• Certificate of Analysis (COA): Issued with every B2B batch.

• Sedation: Cetirizine may cause drowsiness; avoid driving.
• Cardiovascular: Phenylephrine may increase blood pressure.
• Contraindications: Hypersensitivity to any component; severe hypertension.

For third-party manufacturing enquiries, private-label contracts, or to request pricing and packaging options for Cetirizine + Paracetamol + Phenylephrine Syrup, please use the B2B enquiry form below.